Search research articles
Contact Us
Filters
Showing results (111-120 of 315) with videos related to
Page
of 32
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 1, 1979
Oligoclonal banding in the cerebrospinal fluid of patients with postencephalitic Parkinsonism
A Williams, S Houff, A Lees, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1973
Parkinsonism treated with 3-O-methyldopa
D B Calne, J L Reid, S D Vakil
Journal of Neural Transmission (Vienna, Austria : 1996)
|
October 14, 2004
Functional imaging in Tourette's syndrome
J R Adams, A R Troiano, D B Calne
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
November 1, 1986
Dementia in movement disorders
H Teräväinen, M Hietanen, J Stoessl, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1977
Treatment of parkinsonism
D B Calne, P F Teychenne, R F Pfeiffer
Annals of Internal Medicine
|
February 1, 1979
Advances in the neuropharmacology of Parkinsonism
D B Calne, J Kebabian, E Silbergeld, et al.
Lancet (London, England)
|
November 8, 1986
Alzheimer's disease, Parkinson's disease, and motoneurone disease: abiotrophic interaction between ageing and environment?
D B Calne, A Eisen, E McGeer, et al.
British Journal of Pharmacology
|
May 1, 1970
The effects of dopamine, L-dopa, L-tyrosine, and pyridoxine on sympathetic nerve endings in man
D B Calne, T M French, A S Spiers
Communications in Psychopharmacology
|
January 1, 1977
Lergotrile mesylate: an in vivo dopamine agonist which blocks dopamine receptors in vitro
J W Kebabian, D B Calne, P R Kebabian
Monographs in Human Genetics
|
January 1, 1972
Autosomal dominant forms of hereditary hypertrophic neuropathy
P K Thomas, D B Calne, R H King
Page
of 32
Search research articles
Search
Showing results (111-120 of 315) with videos related to
Sort By:
Page
of 32
Journal of Neurology, Neurosurgery, and Psychiatry
|
September 1, 1979
Oligoclonal banding in the cerebrospinal fluid of patients with postencephalitic Parkinsonism
A Williams, S Houff, A Lees, et al.
Clinical Pharmacology and Therapeutics
|
May 1, 1973
Parkinsonism treated with 3-O-methyldopa
D B Calne, J L Reid, S D Vakil
Journal of Neural Transmission (Vienna, Austria : 1996)
|
October 14, 2004
Functional imaging in Tourette's syndrome
J R Adams, A R Troiano, D B Calne
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques
|
November 1, 1986
Dementia in movement disorders
H Teräväinen, M Hietanen, J Stoessl, et al.
Advances in Experimental Medicine and Biology
|
January 1, 1977
Treatment of parkinsonism
D B Calne, P F Teychenne, R F Pfeiffer
Annals of Internal Medicine
|
February 1, 1979
Advances in the neuropharmacology of Parkinsonism
D B Calne, J Kebabian, E Silbergeld, et al.
Lancet (London, England)
|
November 8, 1986
Alzheimer's disease, Parkinson's disease, and motoneurone disease: abiotrophic interaction between ageing and environment?
D B Calne, A Eisen, E McGeer, et al.
British Journal of Pharmacology
|
May 1, 1970
The effects of dopamine, L-dopa, L-tyrosine, and pyridoxine on sympathetic nerve endings in man
D B Calne, T M French, A S Spiers
Communications in Psychopharmacology
|
January 1, 1977
Lergotrile mesylate: an in vivo dopamine agonist which blocks dopamine receptors in vitro
J W Kebabian, D B Calne, P R Kebabian
Monographs in Human Genetics
|
January 1, 1972
Autosomal dominant forms of hereditary hypertrophic neuropathy
P K Thomas, D B Calne, R H King
Page
of 32